Diffusion MR Gradient Maps for Breast Lesion Discrimination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current Diffusion Weighted Imaging (DWI) and Diffusion Tensor Imaging (DTI) methods for breast cancer detection face limitations, including insufficient sensitivity for standalone breast cancer detection due to overlap in ADC values between benign and malignant lesions, and the need for contrast agents, which can be costly and cause adverse reactions.
Innovation Solution
A method and device that generate novel maps from diffusion MR image data by performing scans at different b-values, using logarithmic functions to enhance lesion conspicuity and employing threshold levels to characterize gradient patterns, thereby improving the discrimination of malignant from benign lesions without the need for contrast agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional DWI/DTI methods are used for breast cancer detection, then the imaging can be performed without contrast agents, but the sensitivity and specificity are insufficient due to overlap in ADC values between benign and malignant lesions
Solution Approach 1:
The patent transitions from conventional 2D ADC value analysis to 3D spatial gradient analysis by computing gradients in multiple directions (x, y, z axes) and combining them into a comprehensive gradient magnitude map. This dimensional expansion enables differentiation of lesions based on their spatial gradient characteristics rather than relying solely on ADC values, thereby improving lesion discrimination capability between benign and malignant lesions.
Solution Approach 2:
The patent introduces a new parameter - the gradient magnitude - derived from the spatial variation of ADC values across multiple directions. By computing gradients in the x, y, and z directions and combining them through the formula gradient magnitude = sqrt((∂ADC/∂x)² + (∂ADC/∂y)² + (∂ADC/∂z)²), the system creates a new diagnostic dimension that complements traditional ADC values, enhancing the ability to distinguish malignant from benign lesions.
2Reliability
If dynamic contrast enhanced (DCE) imaging is used for breast cancer detection, then the sensitivity for detecting vascularization is high, but the cost and adverse reactions from contrast agents increase
Solution Approach 1:
The patent employs the body's own tissue properties - specifically the diffusion characteristics of water molecules in different tissue environments - as the diagnostic signal source. By measuring ADC values and computing their spatial gradients, the system utilizes inherent tissue differences in water diffusion (caused by cellular density, membrane integrity, and extracellular matrix composition) to characterize lesions, eliminating the need for external contrast agents and their associated risks.
Solution Approach 2:
The patent replaces the contrast agent-based detection mechanism with a diffusion-based mechanism. Instead of relying on contrast agents to highlight vascularization, the system uses diffusion-weighted imaging to detect and characterize lesions based on the random motion of water molecules, substituting a chemical contrast mechanism with a physical diffusion process that provides complementary diagnostic information.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the detection and discrimination of malignant lesions, providing more accurate diagnostic information and reducing costs and morbidity by eliminating the need for contrast agents, while improving sensitivity and specificity for breast cancer diagnosis.
Implementation Method 1
Diffusion Tensor Imaging (DTI) measures the magnitude and direction of random motion of water molecules
Implementation Method 2
The physiological basis of using DWI/DTI for cancer diagnosis is that the densely packed cells within a cancer restrict the normal random motion (Brownian motion) that occurs within all cells
Implementation Method 3
Diffusion Weighted Imaging (DWI) ... requires the acquisition of signals in at least 6 directions
Data Source
AI summary
A method for generating a map of a region of a patient's body containing one or more lesions that provides information about MR diffusion properties and/or level of suspicion of malignancy. Performing at least one first scan of the region with an MRI apparatus set to a first b value to obtain a first matrix of pixel or voxel values, int(B1); performing at least one second scan of the region with the apparatus set to a second b value to obtain a second matrix of pixel or voxel intensity values, int(B2); deriving a first computed value that is a monotonic function of ln(int(B1)/int(B2); multiplying each computed value by a value proportional to int (B1) to obtain a second computed value; and producing a representation of all the second computed values that is indicative of the likelihood that one or more of the lesions are malignant.